New enzyme therapy aims to help cystic fibrosis patients digest food
NCT ID NCT07450547
Summary
This study is testing whether a new enzyme therapy called ANG003 works as well as the standard treatment (Creon) for people with cystic fibrosis who have trouble digesting food. About 113 participants aged 12+ with cystic fibrosis and severe pancreatic insufficiency will try either ANG003 at different doses or Creon. Researchers will compare how well each treatment helps the body absorb fats and nutrients from food, while monitoring safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS (CF) are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.